I know when you bought your "position as a serious purchase."
Here is another question for you. If CIT is worth developing, why did Radient/NuVax abandon it in December 2010 and license Chang's newer technology from the University of Florida in January 2011?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.